Rights and permissions
About this article
Cite this article
New premium price expected with launch of teriparatide. Pharmacoecon. Outcomes News 393, 11 (2002). https://doi.org/10.1007/BF03280011
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280011